Sign In
Buy DXCM
$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
Growth stocks remain resilient in weakening economy, says Neuberger's Jason Tauber
05:13pm, Friday, 08'th Jul 2022
Jason Tauber, Neuberger Berman large cap disciplined growth and the disruptors portfolio manager, joins 'Closing Bell: Overtime' to discus his bullish case for the growth trade.
DexCom: Long Term Secular Growth Beneficiary
03:06pm, Friday, 08'th Jul 2022
DexCom has a leading position in a huge and growing market of continuous glucose monitoring. Medical technology is a growing space, with powerful demographic forces leading to outsized long-term growt
Dexcom Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022 at 4:30 p.m. Eastern Time.
04:04pm, Thursday, 30'th Jun 2022
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2022 financial results after market close on Thursday, July 28, 2022. Management will
With Stock Splits Underway, These 2 Beaten-Down Stocks Are Buys Now
10:23am, Wednesday, 29'th Jun 2022
Don't be too quick to give up on these companies.
3 Stock-Split Stocks You Can Confidently Buy and Hold Forever
05:06am, Tuesday, 28'th Jun 2022
Among the high-profile stocks splitting their shares in 2022, these three offer the most attractive long-term growth prospects.
Here's Why You Should Hold on to DexCom (DXCM) Stock Now
12:27pm, Monday, 20'th Jun 2022
DexCom (DXCM) continues to benefit from a solid product portfolio and a strong international presence. However, supply constraints remain a woe.
2 Beaten-Down Stocks With 80% to 113% Upside, According to Wall Street
11:30am, Wednesday, 08'th Jun 2022
These diabetes specialists are down but not out.
Will a Stock Split Help Rally These 2 Underperforming Nasdaq Stocks?
10:15am, Wednesday, 08'th Jun 2022
Both of these stocks are down by more than 19% this year.
DexCom (DXCM) to Boost Diabetes Management With New Coverage
12:49pm, Thursday, 02'nd Jun 2022
DexCom's (DXCM) G6 CGM System gets public coverage through Prince Edward Island's Diabetes Glucose Sensor Program, which can aid in effective diabetes management.
2 of the Nasdaq's Best Long-Term Buys Right Now
10:15am, Thursday, 02'nd Jun 2022
You can buy and forget about these stocks.
Why DexCom Stock Is Jumping Today
11:12am, Tuesday, 31'st May 2022
The company confirmed that it isn't in merger discussions with Insulet.
DexCom stock leads S&P 500's premarket gainers after denying merger talks, and Insulet stock drops
09:26am, Tuesday, 31'st May 2022
Shares of DexCom Inc. DXCM, +5.35% surged 8.1% to pace the S&P 500's SPX, -0.37% premarket gainers, after the diabetes care company said it was not currently in "active discussions" regarding a merger
What Makes DexCom Stock A Better Pick Over This Insulin Pump Maker?
06:00am, Friday, 27'th May 2022
We believe that this gap in the valuation of these two companies does not make sense, given that DexCom has demonstrated better revenue growth and profitability than Insulet.
Why DexCom Is Down More Than 11% on Tuesday
12:56pm, Tuesday, 24'th May 2022
Whispers of an acquisition aren't being well received by already nervous shareholders, who may be questioning the timing as well as the potential of such a deal.
PODD Stock Pops 7% as DexCom Considers Insulet Corporation Acquisition
10:52am, Tuesday, 24'th May 2022
Insulet (PODD) stock is heading higher on Tuesday as investors react to reports that DexCom (DXCM) is considering acquiring the company. The post PODD Stock Pops 7% as DexCom Considers Insulet Corpora
